Home > Quotes > ABT > Company News

Abbott Laboratories News Headlines

ABT 
$36.21
*  
1.30
  negative  
3.47%
Get ABT Alerts
*Delayed - data as of Jun. 19, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ABT After Hours
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
4/5/2013 8:53:00 AM - Dow Jones Business News

UPDATE: U.S. Appeals Court Reverses $593 Million Award Against J&J
4/4/2013 4:50:00 PM - Dow Jones Business News

Appeals Court Reverses $593 Million Award Against J&J
4/4/2013 4:45:00 PM - Dow Jones Business News

U.S. Appeals Court Reverses $593 Million Award Against J&J
4/4/2013 4:09:00 PM - Dow Jones Business News

Pharma & Biotech Stock Outlook - Apr 2013 - Industry Outlook
4/4/2013 3:04:01 AM - Zacks.com

Pharma & Biotech Stock Outlook - Apr 2013 - Zacks Analyst Interviews
4/4/2013 3:04:01 AM - Zacks.com

TSX Plummets To End At 3-Month Low On Soft Data - Canadian Commentary
4/3/2013 4:47:00 PM - RTT News

TSX Dips On Downbeat US Data - Canadian Commentary
4/3/2013 11:01:00 AM - RTT News

Stock Market News for April 3, 2013 - Market News
4/3/2013 10:24:09 AM - Zacks.com

TSX Poised For Flat Open - Canadian Commentary
4/3/2013 8:56:00 AM - RTT News

Absolute Software Enters Into Partnership With Samsung Electronics
4/3/2013 7:31:00 AM - RTT News

Setback for Novartis in India - Analyst Blog
4/2/2013 6:19:11 PM - Zacks.com

4 Companies Generating Income From The Business Of Babies
4/2/2013 1:08:00 PM - Seeking Alpha

Glaxo's Influenza Vaccine Gets CRL - Analyst Blog
4/1/2013 6:50:01 PM - Zacks.com

Lilly Progresses with Empagliflozin - Analyst Blog
4/1/2013 6:07:01 PM - Zacks.com

AbbVie Offers Nice Dividend Yield, Stock At New High
4/1/2013 5:23:00 PM - Investor's Business Daily

Sanofi Invests in Emerging Markets - Analyst Blog
4/1/2013 5:10:27 PM - Zacks.com

Apricus Biosciences: A Transformative Year Ahead
4/1/2013 3:43:00 PM - Seeking Alpha

Abaxis Pinned at Neutral - Analyst Blog
4/1/2013 3:06:38 PM - Zacks.com

Roche Mulls Bid For Genetic Sequencing Company Life Technologies
4/1/2013 1:00:32 PM - Trefis

Sanofi/Transgene Inks Immunotherapy Deal - Analyst Blog
3/28/2013 6:30:43 PM - Zacks.com

FDA Approves Novartis' TOBI Podhaler - Analyst Blog
3/28/2013 5:26:42 PM - Zacks.com

Is It Time To Buy AbbVie?
3/28/2013 3:41:00 PM - Seeking Alpha

What Lessons Does Cyprus Teach Us? - Analyst Blog
3/28/2013 12:29:50 PM - Zacks.com

Is Anacor's Latest Drug Development A Potential Blockbuster?
3/28/2013 11:27:00 AM - Seeking Alpha